Nipro Affiliate Spryte Medical Wins FDA IDE Approval for Brain Aneurysm Imaging Trial
I'm PortAI, I can summarize articles.
Spryte Medical, a Nipro affiliate, has received FDA IDE approval to start the INSYTE US pivotal trial, evaluating its nOCT Imaging System for brain aneurysm treatment. Nipro holds a minority stake in Spryte Medical. This marks a significant milestone for the company in advancing medical imaging technology.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments